We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
726
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$380K ﹤0.01%
4,195
– –
MNDT
727
DELISTED
Mandiant, Inc. Common Stock
MNDT
$378K ﹤0.01%
22,500
– –
QCLS
728
Q/C Technologies Inc
QCLS
$25.3M
$377K ﹤0.01%
3
+1
+50% +$159K
ABUS icon
729
Arbutus Biopharma
ABUS
$871M
$376K ﹤0.01%
105,000
– –
CVSA
730
Covista Inc
CVSA
$4.09B
$371K ﹤0.01%
8,000
– –
PNQI icon
731
Invesco NASDAQ Internet ETF
PNQI
$514M
$371K ﹤0.01%
13,750
– –
AEM icon
732
Agnico Eagle Mines
AEM
$73B
$360K ﹤0.01%
8,283
-21,750
-72% -$920K
IX icon
733
ORIX
IX
$43.9B
$359K ﹤0.01%
25
-5
-17% -$74
VOYA icon
734
Voya Financial
VOYA
$8.98B
$352K ﹤0.01%
7,044
– –
AUO
735
DELISTED
AU Optronics Corp
AUO
$351K ﹤0.01%
96,327
– –
MDRX
736
DELISTED
Veradigm Inc. Common Stock
MDRX
$334K ﹤0.01%
35,000
– –
AMG icon
737
Affiliated Managers Group
AMG
$9.61B
$328K ﹤0.01%
3,060
+360
+13% +$38.2K
VALE icon
738
Vale
VALE
$62.9B
$328K ﹤0.01%
25,125
-9,210
-27% -$119K
QSR icon
739
Restaurant Brands International
QSR
$25.8B
$327K ﹤0.01%
5,024
+336
+7% +$20.6K
FOX icon
740
Fox Class B
FOX
$21.3B
$325K ﹤0.01%
+9,055
New +$345K
CIB icon
741
Grupo Cibest SA
CIB
$20.9B
$322K ﹤0.01%
6,314
– –
QTRX icon
742
Quanterix
QTRX
$173M
$310K ﹤0.01%
+12,000
New +$268K
CVE icon
743
Cenovus Energy
CVE
$52.3B
$287K ﹤0.01%
33,012
– –
POWI icon
744
Power Integrations
POWI
$3.53B
$280K ﹤0.01%
8,014
+90
+1% +$3.06K
SLG icon
745
SL Green Realty
SLG
$3.83B
$275K ﹤0.01%
3,162
– –
KT icon
746
KT
KT
$8.92B
$248K ﹤0.01%
19,965
– –
PE
747
DELISTED
PARSLEY ENERGY INC
PE
$239K ﹤0.01%
+12,372
New +$227K
RJF icon
748
Raymond James Financial
RJF
$33.3B
$225K ﹤0.01%
4,193
-40,417
-91% -$2.16M
CIG icon
749
CEMIG Preferred Shares
CIG
$6.18B
$215K ﹤0.01%
118,289
– –
DVA icon
750
DaVita
DVA
$15.2B
$214K ﹤0.01%
3,945
-53,744
-93% -$2.97M
28 29
30
31 32

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.